Prenosis Inc. gained U.S. FDA de novo marketing authorization for an artificial intelligence-powered rapid diagnostic tool for sepsis, one of the most challenging and deadly conditions in hospitals ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback